As a subsequent result, poor immune infiltration and therapeutic response may occur, leading us to postulate that Gli-mediated Hedgehog signaling could be an early indicator of immune exclusion and poor prognosis for DDLPS moving forward. The gene discussed is GLI1; the disease is dedifferentiated liposarcoma.